Highlights InterCure Ltd.

Stocks

INCR

IL0011063760

Healthcare Facilities & Services

Market Closed - TEL AVIV STOCK EXCHANGE Other stock markets 11:44:05 12/06/2026 BST			5-day change	1st Jan Change
262.80 ^ILa	+0.73%		-12.22%	-18.79%

04-30	InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-03	InterCure Receives Noncompliance Notice From Nasdaq	MT

Highlights

04-30	InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-03	InterCure Receives Noncompliance Notice From Nasdaq	MT
02-19	InterCure announces preliminary estimated 2025 revenue of NIS 265 million, positive adjusted EBITDA and cash of NIS 43 million	RE
12-18	InterCure Ltd on Dec 15, became aware that Bazelet Group of Companies has initiated Restructuring proceedings before the Israeli district court	RE
11-03	InterCure Ltd. Enters into A Collaboration Agreement with Cannasoul R&D Ltd	CI
08/10/25	InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
08/10/25	Intercure reports first half 2025 results with NIS 130 million in revenue and positive operating cash flow	RE
08/10/25	InterCure Ltd H1 2025 revenue NIS 130 million	RE
19/09/25	InterCure to Acquire Cannabis Brand Botanico in Two-Phase Deal	MT
19/09/25	Intercure to buy ISHI, gaining access to premium U.S. cannabis tech and brands	RE
18/09/25	InterCure Ltd. agreed to acquire Botanico Ltd. for ILS 25.3 million.	CI
01/05/25	InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
29/08/24	InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
28/08/24	InterCure Partners with Cookies to Launch Branded Products in Germany	MT
28/08/24	InterCure Announces Expansion of its Strategic Partnership with Cookies to Germany	CI
01/05/24	InterCure Ltd. Provides Revenue Guidance for the Full Year 2024	CI
01/05/24	InterCure Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
01/04/24	InterCure Ltd. Provides Earnings Guidance for the Second Half and Full Year of 2023	CI
22/03/24	InterCure Ltd. Expects to Launch Its First Products in Germany in the Coming Months	CI
30/01/24	InterCure Ltd. entered into a share purchase agreement to acquire Leon Pharm Ltd for ILS 8.3 million.	CI
01/09/23	InterCure Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	CI
12/06/23	InterCure Provides Update About Lawsuit it Filed Against Cann Pharmaceuticals to Recover Funds Following Failed Merger	MT
15/11/22	InterCure Ltd. entered into an agreement to acquire 51% stake in Orni Pharmacy Ltd.	CI
16/08/21	InterCure Ltd. Announces Earnings Results for the Second Quarter Ended June 30, 2021	CI
04/04/21	InterCure Ltd signed a Letter of Intent to acquire Cann Pharmaceutical Ltd. for $35 million.	CI